A Trial of Pasireotide and Everolimus in Adult Patients With Radioiodine-Refractory Differentiated and Medullary Thyroid Cancer

This study is currently recruiting participants. (see Contacts and Locations)
Verified April 2015 by Emory University
Sponsor:
Collaborator:
Novartis
Information provided by (Responsible Party):
Taofeek K. Owonikoko, Emory University
ClinicalTrials.gov Identifier:
NCT01270321
First received: January 4, 2011
Last updated: April 7, 2015
Last verified: April 2015
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: June 2016
  Estimated Primary Completion Date: October 2015 (Final data collection date for primary outcome measure)